Literature DB >> 15328560

Mitochondrial DNA depletion in Alpers syndrome.

M Tesarova1, J A Mayr, L Wenchich, H Hansikova, M Elleder, K Blahova, W Sperl, J Zeman.   

Abstract

Mitochondrial dysfunction of the energy generating system was suggested in two infants with progressive infantile poliodystrophy characterised by hypotonia, refractory epilepsy, visual impairment, psychomotor retardation, profound brain atrophy, hepatopathy, and increased levels of lactate in blood and cerebrospinal fluid. Histochemical and electron microscopic analyses of liver biopsies revealed cytochrome c oxidase deficiency, microvesicular steatosis, and enormous multiplication of mitochondria of various sizes. In the first patient, the quantitative Southern blot analyses in tissues obtained at autopsy demonstrated reduced content of mtDNA in the liver, brain, and fibroblasts (11 %, 15 %, and 25 % of the mean values in controls) while a normal content of mtDNA was found in muscle and heart. In the second patient, a reduced content of mtDNA was found in the muscle, liver, and brain (15 %, 10 %, and 30 %, respectively, of the mean values in controls). Biochemical studies in the first patient revealed decreased activities of all respiratory chain complexes except complex II in isolated liver mitochondria and decreased amounts of respiratory chain complexes I, III, IV and ATP synthase in liver and frontal cortex, but not in muscle, heart, and fibroblasts. In conclusions, mtDNA depletion associated with Alpers syndrome may be tissue specific.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15328560     DOI: 10.1055/s-2004-821081

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  5 in total

1.  Drug-resistant epilepsia and fulminant valproate liver toxicity. Alpers-Huttenlocher syndrome in two children confirmed post mortem by identification of p.W748S mutation in POLG gene.

Authors:  Ewa Pronicka; Anna Weglewska-Jurkiewicz; Maciej Pronicki; Jolanta Sykut-Cegielska; Pawel Kowalski; Magdalena Pajdowska; Irena Jankowska; Katarzyna Kotulska; Piotr Kalicinski; Joanna Jakobkiewicz-Banecka; Grzegorz Wegrzyn
Journal:  Med Sci Monit       Date:  2011-04

2.  A statistical algorithm showing coenzyme Q10 and citrate synthase as biomarkers for mitochondrial respiratory chain enzyme activities.

Authors:  D Yubero; A Adin; R Montero; C Jou; C Jiménez-Mallebrera; A García-Cazorla; A Nascimento; M M O'Callaghan; J Montoya; L Gort; P Navas; A Ribes; M D Ugarte; R Artuch
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379

3.  Understanding mitochondrial DNA maintenance disorders at the single muscle fibre level.

Authors:  Diana Lehmann; Helen A L Tuppen; Georgia E Campbell; Charlotte L Alston; Conor Lawless; Hannah S Rosa; Mariana C Rocha; Amy K Reeve; Thomas J Nicholls; Marcus Deschauer; Stephan Zierz; Robert W Taylor; Doug M Turnbull; Amy E Vincent
Journal:  Nucleic Acids Res       Date:  2019-08-22       Impact factor: 16.971

4.  Prospective study of POLG mutations presenting in children with intractable epilepsy: prevalence and clinical features.

Authors:  Johanna Uusimaa; Vasantha Gowda; Anthony McShane; Conrad Smith; Julie Evans; Annie Shrier; Manisha Narasimhan; Anthony O'Rourke; Yusuf Rajabally; Tammy Hedderly; Frances Cowan; Carl Fratter; Joanna Poulton
Journal:  Epilepsia       Date:  2013-02-28       Impact factor: 5.864

5.  Mitochondrial DNA depletion and fatal infantile hepatic failure due to mutations in the mitochondrial polymerase γ (POLG) gene: a combined morphological/enzyme histochemical and immunocytochemical/biochemical and molecular genetic study.

Authors:  J Müller-Höcker; R Horvath; S Schäfer; H Hessel; W Müller-Felber; J Kühr; W C Copeland; P Seibel
Journal:  J Cell Mol Med       Date:  2011-02       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.